Thrombin Stimulated Platelet-Derived Exosomes Inhibit Platelet-Derived Growth Factor Receptor-Beta Expression in Vascular Smooth Muscle Cells

Cellular Physiology and Biochemistry

Volumn 38, Issue 6, 2016, Pages 2348-2365

  Tan, Ming ^a   Yan, Hong Bing ^a   Li, Jian Nan ^a   Li, Wen Ke ^a   Fu, Yuan Yuan ^a   Chen, Wen ^a   Zhou, Zhou ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Atherothrombosis; Exosome; MicroRNA; Platelet; Platelet Derived growth factor receptor beta; Smooth muscle cell

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; K RAS PROTEIN; MICRORNA; MICRORNA 21; MICRORNA 223; MICRORNA 339; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE C; THROMBIN; UNCLASSIFIED DRUG; MIRN-21 MICRORNA, MOUSE; MIRN-339 MICRORNA, MOUSE; MIRN223 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXOSOME; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE ACTIVATION; THROMBOSIS; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ANIMAL; BLOOD; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SMOOTH MUSCLE CELL; THROMBOCYTE; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD PLATELETS; EXOSOMES; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE, INBRED C57BL; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLATELET ACTIVATION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; THROMBIN; THROMBOSIS; UP-REGULATION;

EID: 84975684630     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000445588     Document Type: Article

References (51)

1. FinnAV, Nakano M, Narula J, Kolodgie FD, Virmani R: Concept of vulnerable/unstable plaque. Arterioscler Thromb Vase Biol 2010;30:1282-1292.
2. Alfieri 0, Mayosi BM, Park SJ, Sarrafzadegan N, Virmani R: Exploring unknowns in cardiology. Nat Rev Cardiol2014;ll:664-670.
3. Stone GW, Maehara A, LanskyAJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW: Aprospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-235.
4. Arbab-Zadeh A, Fuster V: The myth ofthe "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol 2015;65:846-855.
5. Giri S, Jennings LK: The spectrum of thrombin in acute coronary syndromes. Thromb Res 2015;135:782-787.
6. Weitz JI: Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome. Thromb Haemost2014;112:924-931.
7. Martin JF, Kristensen SD, Mathur A, Grove EL, Choudry FA: The causal role of megakaryocyte-platelet hyperactivity in acute coronary syndromes. Nat Rev Cardiol 2012;9:658-670.
8. Sasaki T, Kuzuya M, Nakamura K, Cheng XW, Shibata T, Sato K, Iguchi A: A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arterioscler Thromb Vase Biol 2006;26:1304-1309.
9. Clarke MC, Figg N, Maguire JJ, DavenportAP, Goddard M, Littlewood TD, Bennett MR: Apoptosis ofvascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006;12:1075-1080.
10. Chen YC, Bui AV, Diesch J, Manasseh R, Hausding C, Rivera J, Haviv I, Agrotis A, Htun NM, Jowett J, Hagemeyer CE, Hannan RD, BobikA, Peter K: A novel mouse model of atherosclerotic plaque instabilityfor drugtesting and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ Res2013;113:252-265.
11. Caro CG: Discovery of the role of wall shear in atherosclerosis. Arterioscler Thromb Vase Biol 2009;29:158-161.
12. Slager CJ, Wentzel JJ, Gijsen FJ, Thury A, van der Wal AC, Schaar JA, Serruys PW: The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract Cardiovasc Med 2005;2:456-464.
13. Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P: Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009;16:961-966.
14. Dangwal S, Thum T: MicroRNAs in platelet biogenesis and function. Thromb Haemost 2012;108:599-604.
15. Edelstein LC, McKenzie SE, Shaw C, Holinstat MA, Kunapuli SP, Bray PF: MicroRNAs in platelet production and activation. J Thromb Haemost2013;ll:S340-350.
16. Osman A, Falker K: Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 2011;22:433-441.
17. Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, Kirkby NS, Crosby-Nwaobi R, Prokopi M, Drozdov I, Langley SR, Sivaprasad S, Markus HS, Mitchell JA, Warner TD, Kiechl S, Mayr M: Circulating microRNAs as novel biomarkers for platelet activation. Circ Res 2013;112:595-600.
18. Colombo M, Raposo G, Thery C: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellularvesicles. Annu Rev Cell Dev Biol 2014;30:255-289.
19. Hoefer IE, Steffens S, Ala-Korpela M, Back M, Badimon L, Bochaton-Piallat ML, Boulanger CM, Caligiuri G, Dimmeler S, Egido J, Evans PC, Guzik T, Kwak BR, Landmesser U, Mayr M, Monaco C, Pasterkamp G, Tunon I, Weber C: Novel methodologies for biomarker discovery in atherosclerosis. Eur Heart J 2015;14;36:2635-2642.
20. Aatonen MT, Ohman T, Nyman TA, Laitinen S, Gronholm M, Siljander PR: Isolation and characterization of platelet-derived extracellularvesicles. J ExtracellVesicles 2014;3: doi: 10.3402/jev.v3.24692. eCollection 2014.
21. Arraud N, Linares R, Tan S, Gounou C, Pasquet JM, Mornet S, Brisson AR: Extracellular vesicles from blood plasma: determination oftheir morphology size, phenotype and concentration. J Thromb Haemost 2014;12:614-627.
22. Laffont B, Corduan A, Pie H, Duchez AC, Cloutier N, Boilard E, Provost P: Activated platelets can deliver mRNA regulatoryAgo2 microRNA complexes to endothelial cells via microparticles. Blood 2013;122:253-261.
23. Gambim MH, do Carmo Ade 0, Marti L, Verissimo-Filho S, Lopes LR, Janiszewski M: Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction. Crit Care 2007;11:R107.
24. Uryga AK, Bennett MR: Ageing induced vascular smooth muscle cell senescence in atherosclerosis. J Physiol 2015;15;594:2115-2124.
25. Silverman-Gavrila R, Silverman-Gavrila L, Bendeck MP: Cell division fidelity is altered duringthe vascular response to injury: its novel role in atherosclerosis progression. Am J Pathol 2013;182:628-639.
26. Bauriedel G, Hutter R, Welsch U, Bach R, Sievert H, Luderitz B: Role of smooth muscle cell death in advanced coronaryprimary lesions: implications for plaque instability. Cardiovasc Res 1999;41:480-488.
27. Golovina VA, Blaustein MP: Preparation of primary cultured mesenteric artery smooth muscle cells for fluorescent imaging and physiological studies. Nat Protoc 2006;1:2681-2687.
28. Roucourt B, Meeussen S, Bao J, Zimmermann P, David G: Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Cell Res 2015;25:412-428.
29. Vlachos IS, Paraskevopoulou MD, Karagkouni D, Georgakilas G, Vergoulis T, Kanellos I, Anastasopoulos IL, Maniou S, Karathanou K, Kalfakakou D, Fevgas A, Dalamagas T, Hatzigeorgiou AG: DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNAmRNA interactions. Nucleic Acids Res 2015;43:D153-159.
30. Huang da W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
31. Motoyama S, Ito H, Sarai M, Kondo T, Kawai H, Nagahara Y, Harigaya H, Kan S, Anno H, Takahashi H, Naruse H, Ishii J, Hecht H, Shaw LJ, Ozaki Y Narula J: Plaque Characterization by Coronary Computed Tomography Angiography and the Likelihood of Acute Coronary Events in Mid-Term Follow-Up. J Am Coll Cardiol 2015;66:337-346.
32. Libby P, Pasterkamp G: Requiem forthe 'vulnerable plaque'. Eur HeartJ 2015;36:2984-2987.
33. Rittersma SZ, van der Wal AC, Koch KT, Piek JJ, Henriques JP, Mulder KJ, Ploegmakers JP, Meesterman M, de Winter RJ: Plaque instabilityfrequently occurs days or weeks before occlusive coronarythrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005;111:1160-1165.
34. NewbyAC, George SJ: Proliferation, migration, matrixturnover, and death of smooth muscle cells in native coronaryandvein graftatherosclerosis. Curr Opin Cardiol 1996;11:574-582.
35. Alexander MR, Owens GK: Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 2012;74:13-40.
36. Strony J, Beaudoin A, Brands D, Adelman B: Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am J Physiol 1993;265:H1787-1796.
37. MailhacA, BadimonJJ, FallonJT, Fernandez-OrtizA, MeyerB, Chesebro JH, FusterV, BadimonL: Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation 1994;90:988-996.
38. Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA: Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med 2012;366:1404-1413.
39. Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM: Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012;366:9-19.
40. Coughlin SR: Thrombin signalling and protease-activated receptors. Nature 2000;407:258-264.
41. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns-Kurosawa DJ, Kurosawa S: Inflammation, sepsis, and coagulation. Haematologica 1999;84:254-259.
42. Jansen F, Yang X, Proebsting S, Hoelscher M, Przybilla D, Baumann K, Schmitz T, Dolf A, Endl E, Franklin BS, Sinning JM, Vasa-Nicotera M, Nickenig G, Werner N: MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am HeartAssoc 2014;3:e001249.
43. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, Mayr A, Weger S, Schett G, Shah A, Boulanger CM, Willeit J, Chowienczyk PJ, Kiechl S, Mayr M: Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 2012;60:290-299.
44. Schulte C, Molz S, Appelbaum S, Karakas M, Ojeda F, Lau DM, Hartmann T, Lackner KJ, Westermann D, Schnabel RB, Blankenberg S, Zeller T: miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort ofPatients with Symptomatic CoronaryArtery Disease. PLoS One2015;10:e0145930.
45. Shan Z, Qin S, Li W, Wu W, Yang J, Chu M, Li X, Huo Y, Schaer GL, Wang S, Zhang C: An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells: Role ofMicroRNA-223 in Smooth Muscle Function and Atherogenesis. J Am Coll Cardiol 2015;65:2526-2537.
46. Ross R, Glomset J, Kariya B, Harker L: A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad SciUSA 1974;71:1207-1210.
47. Karvinen H, Rutanen J, Leppanen 0, Lach R, Levonen AL, Eriksson U, Yla-Herttuala S: PDGF-C and-D and their receptors PDGFR-alpha and PDGFR-beta in atherosclerotic human arteries. Eur J Clin Invest 2009;39:320-327.
48. Liu B, Han M, Sun RH, Wang JJ, Liu YP, Wen JK: Acetylbritannilactone induces Gl arrest and apoptosis in vascular smooth muscle cells. Int J Cardiol 2011;149:30-38.
49. Bornfeldt KE, Campbell JS, Koyama H, Argast GM, Leslie CC, Raines EW, Krebs EG, Ross R: The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence onthe availabilityof downstreamtargets. J Clin Invest 1997;100:875-885.
50. Page K, Li J, Hershenson MB: Platelet-derived growth factor stimulation of mitogen-activated protein kinases and cyclin Dl promoter activity in cultured airway smooth-muscle cells. Role of Ras. Am J Respir Cell Mol Biol 1999;20:1294-1302.
51. Pakala R: Serotonin and thromboxane A2 stimulate platelet-derived microparticle-induced smooth muscle cell proliferation. Cardiovasc Radiat Med 2004;5:20-26.